Phase 1 MSI-H Cancer Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.

Advanced Solid Tumors CancerMSI-H Cancer

Nimbus Wadjet, Inc.134 enrolled22 locationsNCT06898450

Recruiting

Phase 1

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

Endometrial CancerAdvanced Solid TumorMetastatic Solid Tumor+1 more

MOMA Therapeutics132 enrolled14 locationsNCT06974110